Canadian marijuana company Aurora Cannabis (NYSE:ACB) is one of the most productive competitors in the North American cannabis marketplace, cultivating more than 35,000 kilograms of bulk flower in the third quarter of this year. With its net revenue expanding at a compound annual growth rate of 144% between the start of 2017 and the end of 2019, it’s easy to see why some investors are taking an interest in the company. But it faces serious obstacles to its future success, and it hasn’t had an easy year.
Aurora is nowhere close to being a profitable company, and to make matters worse, its stock has taken a beating this year, contracting by more than 82%. Can Aurora rally its fortunes and return its share price to the wild highs of 2018 and 2019, or are the company’s millionaire-maker days firmly in its…
Original Author Link click here to read complete story..
